‹ All jobs
Senior Business Development Manager
<h1><strong>About Orakl Oncology</strong></h1><p style="min-height:1.5em">Every cancer patient deserves a treatment that works for them. Today, too many never get one in time: fewer than 5% of new cancer drugs make it through clinical trials and every failure costs patients years.</p><p style="min-height:1.5em">Orakl exists to change those odds. We bridge biological and artificial intelligence by building large cohorts of virtual cancer patients: real patients’ tumors, paired with their medical history and deep biological data. Because we can test treatments on these virtual patients at scale, we can predict, with causal evidence, how a patient will respond to a drug long before it reaches the clinic. This helps pharma companies bet on the right drugs, for the right patients, much earlier on.</p><p style="min-height:1.5em">We were founded in 2023 by Fanny Jaulin, PhD, Diane-Laure Pagès and Gustave Ronteix, PhD as a spin-out from Gustave Roussy, one of Europe’s leading cancer centers, and we build on 10 years of research. We are backed by top international VCs and growing fast. Discover more here on <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.orakl-oncology.com/">Orakl’s website</a>.</p><p style="min-height:1.5em"></p><h1><strong>The role</strong></h1><p style="min-height:1.5em">Orakl is looking for a Senior Business Development Manager to build and run its partnership pipeline with pharma and biotech. You will find the right accounts, reach the right people inside them and turn first conversations into qualified opportunities for the VP Business Development. You will own the front end of Orakl’s commercial engine: account strategy, prospecting, discovery and pipeline discipline. You will work closely with the VP BD, the Product Marketer, the scientific teams and the founders, and alongside the Communications & Events Lead on conferences.</p><p style="min-height:1.5em"></p><h2><strong>Prospects: target, position, engage</strong></h2><ul style="min-height:1.5em"><li><p style="min-height:1.5em"><strong>Define where Orakl plays.</strong> Identify and prioritise the pharma and biotech accounts where Orakl’s offerings create the most value, based on their oncology pipelines and development stage.</p></li><li><p style="min-height:1.5em"><strong>Position Orakl’s offer.</strong> Tailor Orakl’s value proposition to each account’s programmes, priorities and decision makers.</p></li><li><p style="min-height:1.5em"><strong>Open new relationships.</strong> Engage decision makers at target accounts through direct outreach and introductions from Orakl’s scientific, clinical and investor network.</p></li><li><p style="min-height:1.5em"><strong>Qualify and convert opportunities.</strong> Assess every lead, inbound or outbound, and lead discovery meetings with VPs to understand their programmes, needs, decision process, budget and timing. Hand qualified opportunities to the VP BD.</p><p style="min-height:1.5em"></p></li></ul><h2><strong>BD team: building the structure</strong></h2><ul style="min-height:1.5em"><li><p style="min-height:1.5em"><strong>Make the pipeline a management tool.</strong> Keep pipeline data reliable so the team and leadership can forecast and decide from it.</p></li><li><p style="min-height:1.5em"><strong>Measure what works.</strong> Track conversion by channel and by stage, and focus effort where it deliv